T-CELL TYPE ACUTE LEUKAEMIA

This adverse event was reported 204 times

These drugs are most commonly taken by patients reporting T-CELL TYPE ACUTE LEUKAEMIA:

# Drug Count
0 CYCLOPHOSPHAMIDE 50
1 CYCLOPHOSPHAMIDE FOR INJECTION 50
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 50
3 METHOTREXATE SODIUM 46
4 METHOTREXATE 45
5 ETOPOSIDE 38
6 DOXORUBICIN 32
7 CYTARABINE 31
8 PREDNISONE 31
9 NELARABINE 21
See all common drugs associated with T-CELL TYPE ACUTE LEUKAEMIA

T-CELL TYPE ACUTE LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NELARABINE 21 0.0216
1 IDARUBICIN HYDROCHLORIDE 6 0.0052
2 DAUNORUBICIN HYDROCHLORIDE 8 0.0049
3 ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN 1 0.0029
4 THIOGUANINE 4 0.0019
5 TAZEMETOSTAT 3 0.0018
6 PEMIGATINIB 1 0.0012
7 CEFPODOXIME PROXETIL 1 0.0010
8 MITOXANTRONE HYDROCHLORIDE 6 0.0010
9 CLOFARABINE 2 0.0009
See all drugs enriched for association with T-CELL TYPE ACUTE LEUKAEMIA